カテゴリ： 世界, 医療/バイオ, Bizwit Research & Consulting

うっ血性心不全薬のグローバル市場（2022年-2029年）：ACE阻害剤、アンジオテンシン2受容体遮断薬、ベータ遮断薬、利尿薬、その他

■ 英語タイトル：Global Congestive Heart Failure Drugs Market Size study & Forecast, by Type (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029

調査会社Bizwit Research & Consulting社が発行したリサーチレポート（データ管理コード：BZW23FE0115）■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23FE0115
■ 発行日：2023年1月29日
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医薬品
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥732,600見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥925,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[うっ血性心不全薬のグローバル市場（2022年-2029年）：ACE阻害剤、アンジオテンシン2受容体遮断薬、ベータ遮断薬、利尿薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Bizwit Research社の市場調査書によると、2021年に約61.5億ドルであった世界のうっ血性心不全薬市場規模は、2022年から2029年の間に年平均14.6％拡大すると予測されています。当書は、うっ血性心不全薬の世界市場を対象にし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、種類別（ACE阻害剤、アンジオテンシン2受容体遮断薬、ベータ遮断薬、利尿薬、その他）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどの項目について調査を行いました。なお、当書には、Bayer AG、Novartis AG、Merck & Co., Inc.、AstraZeneca、Bristol-Myers Squibb Company、Amgen Inc.、Boehringer Ingelheim International GmbH、Pfizer, Inc.、Johnson & Johnson Services, Inc.、Otsuka Pharmaceutical Co., Ltd.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界うっ血性心不全薬市場規模：種類別
- ACE阻害剤の市場規模
- アンジオテンシン2受容体遮断薬の市場規模
- ベータ遮断薬の市場規模
- 利尿薬の市場規模
- その他うっ血性心不全薬の市場規模
・世界うっ血性心不全薬市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
・世界のうっ血性心不全薬市場規模：地域別
- 北米のうっ血性心不全薬市場
- ヨーロッパのうっ血性心不全薬市場
- アジア太平洋のうっ血性心不全薬市場
- 中南米のうっ血性心不全薬市場
- その他地域のうっ血性心不全薬市場
・競争分析
・調査プロセス

Global Congestive Heart Failure Drugs Market is valued at approximately USD 6.15 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.60% over the forecast period 2022-2029. Congestive heart failure (CHF) is a chronic health condition that reduces the pumping of blood in the heart and impacts the ability of the heart muscle. The CHF drugs are specially designed drugs that are used to cure this health problem and aid in increasing the ability of the heart to pump blood effectively. Factors such as the increasing geriatric population, rising product approvals, coupled with growing healthcare expenditure are reinforcing the market demand around the world.

The rising incidences of Congestive Heart Failure (CHF) is a major concern that leads to high morbidity and mortality rate. The Global Health Data Exchange registry reported that the prevalence of congestive heart failure disease was estimated to account for approximately around 64.34 million cases globally, and in the U.S., the incidences were recorded with 5.5 million in 2022. Therefore, the growing cases of CHF are acting as a catalyzing factor for market growth. In addition, the growing R&D for drug development, as well as the strong clinical drugs pipeline are offering various lucrative opportunities over the forecasting years. However, the availability of generic and off-label drugs in the market and poor reimbursement scenarios in developing countries are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Congestive Heart Failure Drugs Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rise in patient awareness, along with the rising government initiatives and implementation of several policies. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing prevalence of congestive heart failure, as well as rising healthcare expenditure in the regional market space.

Major market players included in this report are:
Bayer AG
Novartis AG
Merck & Co., Inc.
AstraZeneca
Bristol-Myers Squibb Company
Amgen Inc.
Boehringer Ingelheim International GmbH
Pfizer, Inc.
Johnson & Johnson Services, Inc.
Otsuka Pharmaceutical Co., Ltd.

Recent Developments in the Market:
 In February 2021, AstraZeneca declared the successful regulatory approval of Forxiga in China. The product has already received approval in the U.S., Europe, and Japan, which indicates heart failure with or without type-2 diabetes in adults.

Global Congestive Heart Failure Drugs Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
ACE Inhibitors
Angiotensin 2 Receptor Blockers
Beta Blockers
Diuretics
Aldosterone Antagonists
Inotropes
Others

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

*** レポート目次（コンテンツ）***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Congestive Heart Failure Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Congestive Heart Failure Drugs Market, by Type, 2019-2029 (USD Billion)
1.2.3. Congestive Heart Failure Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Congestive Heart Failure Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Congestive Heart Failure Drugs Market Dynamics
3.1. Congestive Heart Failure Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising incidences of Congestive heart failure (CHF)
3.1.1.2. Increasing product approvals
3.1.2. Market Challenges
3.1.2.1. Availability of generic and off-label drugs in the market
3.1.2.2. Poor reimbursement scenarios in developing countries
3.1.3. Market Opportunities
3.1.3.1. Growing R&D for drug development
3.1.3.2. Strong clinical drugs pipeline
Chapter 4. Global Congestive Heart Failure Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Congestive Heart Failure Drugs Market, by Type
6.1. Market Snapshot
6.2. Global Congestive Heart Failure Drugs Market by Type, Performance – Potential Analysis
6.3. Global Congestive Heart Failure Drugs Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Congestive Heart Failure Drugs Market, Sub Segment Analysis
6.4.1. ACE Inhibitors
6.4.2. Angiotensin 2 Receptor Blockers
6.4.3. Beta Blockers
6.4.4. Diuretics
6.4.5. Aldosterone Antagonists
6.4.6. Inotropes
6.4.7. Others
Chapter 7. Global Congestive Heart Failure Drugs Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Congestive Heart Failure Drugs Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Congestive Heart Failure Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Congestive Heart Failure Drugs Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Congestive Heart Failure Drugs Market, Regional Analysis
8.1. Congestive Heart Failure Drugs Market, Regional Market Snapshot
8.2. North America Congestive Heart Failure Drugs Market
8.2.1. U.S. Congestive Heart Failure Drugs Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Congestive Heart Failure Drugs Market
8.3. Europe Congestive Heart Failure Drugs Market Snapshot
8.3.1. U.K. Congestive Heart Failure Drugs Market
8.3.2. Germany Congestive Heart Failure Drugs Market
8.3.3. France Congestive Heart Failure Drugs Market
8.3.4. Spain Congestive Heart Failure Drugs Market
8.3.5. Italy Congestive Heart Failure Drugs Market
8.3.6. Rest of Europe Congestive Heart Failure Drugs Market
8.4. Asia-Pacific Congestive Heart Failure Drugs Market Snapshot
8.4.1. China Congestive Heart Failure Drugs Market
8.4.2. India Congestive Heart Failure Drugs Market
8.4.3. Japan Congestive Heart Failure Drugs Market
8.4.4. Australia Congestive Heart Failure Drugs Market
8.4.5. South Korea Congestive Heart Failure Drugs Market
8.4.6. Rest of Asia Pacific Congestive Heart Failure Drugs Market
8.5. Latin America Congestive Heart Failure Drugs Market Snapshot
8.5.1. Brazil Congestive Heart Failure Drugs Market
8.5.2. Mexico Congestive Heart Failure Drugs Market
8.5.3. Rest of Latin America Congestive Heart Failure Drugs Market
8.6. Rest of The World Congestive Heart Failure Drugs Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Bayer AG
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Novartis AG
9.2.3. Merck & Co., Inc.
9.2.4. AstraZeneca
9.2.5. Bristol-Myers Squibb Company
9.2.6. Amgen Inc.
9.2.7. Boehringer Ingelheim International GmbH
9.2.8. Pfizer, Inc.
9.2.9. Johnson & Johnson Services, Inc.
9.2.10. Otsuka Pharmaceutical Co., Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Congestive Heart Failure Drugs Market, report scope
TABLE 2. Global Congestive Heart Failure Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Congestive Heart Failure Drugs Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Congestive Heart Failure Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Congestive Heart Failure Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Congestive Heart Failure Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Congestive Heart Failure Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Congestive Heart Failure Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Congestive Heart Failure Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Congestive Heart Failure Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Congestive Heart Failure Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Congestive Heart Failure Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Congestive Heart Failure Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Congestive Heart Failure Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Congestive Heart Failure Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Congestive Heart Failure Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Congestive Heart Failure Drugs Market
TABLE 70. List of primary sources, used in the study of global Congestive Heart Failure Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 慢性腎臓病治療薬のグローバル市場展望 2023年-2029年：ACE阻害剤、カルシウムチャネル遮断薬、ベータ遮断薬、その他
  • アトピー性皮膚炎薬のグローバル市場（2022年-2029年）：副腎皮質ホルモン、カルシニューリン阻害剤、PDE4阻害剤、バイオ製剤、その他
  • 馬健康管理のグローバル市場（2022年-2029年）：ワクチン、医薬品、薬用飼料添加物、診断、その他
  • 脊髄性筋萎縮症治療のグローバル市場（2022年-2029年）：ヌシネルセン、オナセムノゲンアベパルボベク
  • 医薬品添加剤のグローバル市場（2022年-2029年）：有機化学品（炭水化物）、無機化学品（リン酸カルシウム）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BZW23FE0115 )"うっ血性心不全薬のグローバル市場（2022年-2029年）：ACE阻害剤、アンジオテンシン2受容体遮断薬、ベータ遮断薬、利尿薬、その他" (英文：Global Congestive Heart Failure Drugs Market Size study & Forecast, by Type (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。